Dynatronics (DYNT) Competitors

In the previous week, Vicarious Surgical and Vicarious Surgical both had 1 articles in the media. Dynatronics' average media sentiment score of 0.92 beat Vicarious Surgical's score of 0.00 indicating that Dynatronics is being referred to more favorably in the news media.

Vicarious Surgical has a beta of 1.49, indicating that its stock price is 49% more volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, indicating that its stock price is 69% less volatile than the broader market.

Dynatronics has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

47.3% of Vicarious Surgical shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 9.5% of Vicarious Surgical shares are owned by company insiders. Comparatively, 2.9% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Vicarious Surgical presently has a consensus price target of $7.00, indicating a potential upside of 797.44%. Given Vicarious Surgical's stronger consensus rating and higher probable upside, research analysts clearly believe Vicarious Surgical is more favorable than Dynatronics.

Vicarious Surgical has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Vicarious Surgical's return on equity.

In the previous week, Profusa had 5 more articles in the media than Dynatronics. MarketBeat recorded 6 mentions for Profusa and 1 mentions for Dynatronics. Dynatronics' average media sentiment score of 0.92 beat Profusa's score of 0.39 indicating that Dynatronics is being referred to more favorably in the news media.

Profusa has a beta of 0.47, indicating that its share price is 53% less volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market.

Dynatronics has higher revenue and earnings than Profusa. Profusa is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

9.8% of Profusa shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 11.4% of Profusa shares are owned by company insiders. Comparatively, 2.9% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Given Dynatronics' higher possible upside, analysts plainly believe Dynatronics is more favorable than Profusa.

Profusa has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Profusa's return on equity of 0.00% beat Dynatronics' return on equity.

Bone Biologics has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market.

Given Dynatronics' higher possible upside, analysts plainly believe Dynatronics is more favorable than Bone Biologics.

Bone Biologics has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Bone Biologics' return on equity.

34.3% of Bone Biologics shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 6.1% of Bone Biologics shares are owned by company insiders. Comparatively, 2.9% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Bone Biologics had 2 more articles in the media than Dynatronics. MarketBeat recorded 3 mentions for Bone Biologics and 1 mentions for Dynatronics. Bone Biologics' average media sentiment score of 1.06 beat Dynatronics' score of 0.92 indicating that Bone Biologics is being referred to more favorably in the media.

Dynatronics has higher revenue and earnings than Bone Biologics. Bone Biologics is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Dynatronics has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market. Comparatively, Sonendo has a beta of 2.19, meaning that its share price is 119% more volatile than the broader market.

Dynatronics has a net margin of -8.35% compared to Sonendo's net margin of -92.74%. Dynatronics' return on equity of -41.81% beat Sonendo's return on equity.

4.2% of Dynatronics shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 2.9% of Dynatronics shares are held by insiders. Comparatively, 7.9% of Sonendo shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Dynatronics had 1 more articles in the media than Sonendo. MarketBeat recorded 1 mentions for Dynatronics and 0 mentions for Sonendo. Dynatronics' average media sentiment score of 0.92 beat Sonendo's score of 0.00 indicating that Dynatronics is being referred to more favorably in the media.

Dynatronics has higher earnings, but lower revenue than Sonendo. Sonendo is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.